The American research group IQVIA is close to acquiring the British pharmaceutical developer and manufacturer Quantitative Sciences for approximately $1.1 billion from the investment fund Premira, reports Bloomberg. The deal will allow IQVIA to expand its presence in the early-stage drug development sector; It can be announced as early as Monday. The capitalization of IQVIA has grown since the beginning of the year by about 9% and amounts to about 40.5 billion dollars.